|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hirsch FR, Spreafico A, Novello S, Wood
MD, Simms L and Papotti M: The prognostic and predictive role of
histology in advanced non-small cell lung cancer: A literature
review. J Thorac Oncol. 3:1468–1481. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Crinò L, Weder W, van Meerbeeck J and
Felip E; ESMO Guidelines Working Group: Early stage and locally
advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical
Practice Guidelines for diagnosis, treatment and follow-up. Ann
Oncol. 21(Suppl 5): v103–v115. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pata S, Yaraksa N, Daduang S, Temsiripong
Y, Svasti J, Araki T and Thammasirirak S: Characterization of the
novel antibacterial peptide Leucrocin from crocodile (Crocodylus
siamensis) white blood cell extracts. Dev Comp Immunol. 35:545–553.
2011. View Article : Google Scholar
|
|
5
|
Phosri S, Mahakunakorn P, Lueangsakulthai
J, Jangpromma N, Swatsitang P, Daduang S, Dhiravisit A and
Thammasirirak S: An investigation of antioxidant and
anti-inflammatory activities from blood components of crocodile
(Crocodylus siamensis). Protein J. 33:484–492. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Alley MC, Scudiero DA, Monks A, Hursey ML,
Czerwinski MJ, Fine DL, Abbott BJ, Mayo JG, Shoemaker RH and Boyd
MR: Feasibility of drug screening with panels of human tumor cell
lines using a microculture tetrazolium assay. Cancer Res.
48:589–601. 1988.PubMed/NCBI
|
|
7
|
Kressel M and Groscurth P: Distinction of
apoptotic and necrotic cell death by in situ labelling of
fragmented DNA. Cell Tissue Res. 278:549–556. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Abraham RT: Cell cycle checkpoint
signaling through the ATM and ATR kinases. Genes Dev. 15:2177–2196.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Evan GI and Vousden KH: Proliferation,
cell cycle and apoptosis in cancer. Nature. 411:342–348. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Waga S, Hannon GJ, Beach D and Stillman B:
The p21 inhibitor of cyclin-dependent kinases controls DNA
replication by interaction with PCNA. Nature. 369:574–578. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bellamy CO, Clarke AR, Wyllie AH and
Harrison DJ: p53 Deficiency in liver reduces local control of
survival and proliferation, but does not affect apoptosis after DNA
damage. FASEB J. 11:591–599. 1997.PubMed/NCBI
|
|
12
|
Green DR: Apoptotic pathways: Ten minutes
to dead. Cell. 121:671–674. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cui H, Kong Y and Zhang H: Oxidative
stress, mitochondrial dysfunction, and aging. J Signal Transduct.
2012:6463542012. View Article : Google Scholar
|
|
14
|
Aon MA, Cortassa S and O'Rourke B:
Mitochondrial oscillations in physiology and pathophysiology. Adv
Exp Med Biol. 641:98–117. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Elmore S: Apoptosis: A review of
programmed cell death. Toxicol Pathol. 35:495–516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Haga N, Fujita N and Tsuruo T:
Mitochondrial aggregation precedes cytochrome c release from
mitochondria during apoptosis. Oncogene. 22:5579–5585. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Denecker G, Vercammen D, Declercq W and
Vandenabeele P: Apoptotic and necrotic cell death induced by death
domain receptors. Cell Mol Life Sci. 58:356–370. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fuertes MA, Castilla J, Alonso C and Pérez
JM: Cisplatin biochemical mechanism of action: From cytotoxicity to
induction of cell death through interconnections between apoptotic
and necrotic pathways. Curr Med Chem. 10:257–266. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yang W, Zhang Y, Li Y, Wu Z and Zhu D:
Myostatin induces cyclin D1 degradation to cause cell cycle arrest
through a phosphatidylinositol 3-kinase/AKT/GSK-3 β pathway and is
antagonized by insulin-like growth factor 1. J Biol Chem.
282:3799–3808. 2007. View Article : Google Scholar
|
|
20
|
Vousden KH and Ryan KM: p53 and
metabolism. Nat Rev Cancer. 9:691–700. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Finlan LE and Hupp TR: The life cycle of
p53: A key target in drug development. Apoptosis Pathways as
Targets for Novel Therapies in Cancer and Other Diseases. Los M and
Gibson SB: Springer; New York, NY, USA: pp. 157–172. 2005,
View Article : Google Scholar
|
|
22
|
Yan X, Fraser M, Qiu Q and Tsang BK:
Overexpression of PTEN sensitizes human ovarian cancer cells to
cisplatin-induced apoptosis in a p53-dependent manner. Gynecol
Oncol. 102:348–355. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moghaddam SJ, Li H, Cho SN, Dishop MK,
Wistuba II, Ji L, Kurie JM, Dickey BF and Demayo FJ: Promotion of
lung carcinogenesis by chronic obstructive pulmonary disease-like
airway inflammation in a K-ras-induced mouse model. Am J Respir
Cell Mol Biol. 40:443–453. 2009. View Article : Google Scholar
|
